Cargando…

Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease characterized by interstitial fibrosis and progressive respiratory failure. Pirfenidone and nintedanib slow down but do not stop the progression of IPF. Thus, new compounds with high antifibrotic activity and simultaneously regener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skurikhin, Evgenii, Nebolsin, Vladimir, Widera, Darius, Ermakova, Natalia, Pershina, Olga, Pakhomova, Angelina, Krupin, Vyacheslav, Pan, Edgar, Zhukova, Mariia, Novikov, Fedor, Sandrikina, Lubov, Morozov, Sergey, Kubatiev, Aslan, Dygai, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664690/ https://www.ncbi.nlm.nih.gov/pubmed/33171668 http://dx.doi.org/10.3390/ijms21218380

Ejemplares similares

Spiperone Stimulates Regeneration in Pulmonary Endothelium Damaged by Cigarette Smoke and Lipopolysaccharide
por: Skurikhin, Evgenii, et al.
Publicado: (2021)

Bisamide Derivative of Dicarboxylic Acid Contributes to Restoration of Testicular Tissue Function and Influences Spermatogonial Stem Cells in Metabolic Disorders
por: Pakhomova, Angelina, et al.
Publicado: (2020)

Reprogrammed CD8(+) T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer
por: Skurikhin, Evgenii G., et al.
Publicado: (2022)

Cell Therapy with Human Reprogrammed CD8(+) T-Cells Has Antimetastatic Effects on Lewis Lung Carcinoma in C57BL/6 Mice
por: Skurikhin, Evgenii G., et al.
Publicado: (2022)

Potential of Stem Cells and CART as a Potential Polytherapy for Small Cell Lung Cancer
por: Skurikhin, Evgenii, et al.
Publicado: (2021)

Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis
por: Skurikhin, Evgenii, et al.
Publicado: (2021)

Cancer Stem Cells and Somatic Stem Cells as Potential New Drug Targets, Prognosis Markers, and Therapy Efficacy Predictors in Breast Cancer Treatment
por: Pershina, Olga, et al.
Publicado: (2021)

Antidiabetic Effects of Bisamide Derivative of Dicarboxylic Acid in Metabolic Disorders
por: Pakhomova, Angelina Vladimirovna, et al.
Publicado: (2020)

Gender Differences in the Pharmacological Actions of Pegylated Glucagon-Like Peptide-1 on Endothelial Progenitor Cells and Angiogenic Precursor Cells in a Combination of Metabolic Disorders and Lung Emphysema
por: Pershina, Olga Victorovna, et al.
Publicado: (2019)

Analysis of Circulating Tumor and Cancer Stem Cells Provides New Opportunities in Diagnosis and Treatment of Small Cell Lung Cancer
por: Skurikhin, Evgenii G., et al.
Publicado: (2022)

Anti-Inflammatory and Antifibrotic Potential of Longidaze in Bleomycin-Induced Pulmonary Fibrosis
por: Pakhomova, Angelina, et al.
Publicado: (2023)

Endothelial Progenitor Cells as Pathogenetic and Diagnostic Factors, and Potential Targets for GLP-1 in Combination with Metabolic Syndrome and Chronic Obstructive Pulmonary Disease
por: Skurikhin, Evgenii Germanovich, et al.
Publicado: (2019)

Modulation of Bleomycin-Induced Lung Fibrosis by Pegylated Hyaluronidase and Dopamine Receptor Antagonist in Mice
por: Skurikhin, Evgenii Germanovich, et al.
Publicado: (2015)

Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
por: Bazdyrev, Evgeny, et al.
Publicado: (2022)

Intricacies of GABA(A) Receptor Function: The Critical Role of the β3 Subunit in Norm and Pathology
por: Menzikov, Sergey A., et al.
Publicado: (2021)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

Physiological Role of ATPase for GABA(A) Receptor Resensitization
por: Menzikov, Sergey A., et al.
Publicado: (2022)

Zinc Inhibits the GABA(A)R/ATPase during Postnatal Rat Development: The Role of Cysteine Residue
por: Menzikov, Sergey A., et al.
Publicado: (2023)

Deciphering the Antifibrotic Property of Metformin
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2022)

Editorial: Repair and regenerative mechanisms by stem/progenitor cells and secretome: The golden twenties of translational medicine
por: Gramignoli, Roberto, et al.
Publicado: (2022)

Association of Low Molecular Weight Plasma Aminothiols with the Severity of Coronavirus Disease 2019
por: Kryukov, Evgeny Vladimirovich, et al.
Publicado: (2021)

Plasma S-Adenosylmethionine Is Associated with Lung Injury in COVID-19
por: Kryukov, Evgeny Vladimirovich, et al.
Publicado: (2021)

Origin and Regenerative Potential of Vertebrate Mechanoreceptor-Associated Stem Cells
por: Widera, Darius, et al.
Publicado: (2012)

Antifibrotic Activity of Acylated and Unacylated Ghrelin
por: Angelino, Elia, et al.
Publicado: (2015)

Antifibrotic function of cGKI in the kidney
por: Schlossmann, Jens, et al.
Publicado: (2015)

ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017)

Antifibrotic therapies to control cardiac fibrosis
por: Fan, Zhaobo, et al.
Publicado: (2016)

Antifibrotic therapy to normalize the tumor microenvironment
por: Hauge, Anette, et al.
Publicado: (2020)

Antifibrotic Therapies: Will We Ever Get There?
por: Thompson, Alexander James, et al.
Publicado: (2010)

PPARG as therapeutic target for antifibrotic therapy
por: Ghallab, Ahmed, et al.
Publicado: (2020)

Antifibrotic Roles of RAAS Blockers: Update
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

Editorial: Tissue Repair and Regenerative Mechanisms by Stem/Progenitor Cells and Their Secretome
por: Gramignoli, Roberto, et al.
Publicado: (2019)

Lung Fibrosis after COVID-19: Treatment Prospects
por: Bazdyrev, Evgeny, et al.
Publicado: (2021)

Dilated cardiomyopathy: antifibrotic effect of IGF1
Publicado: (2012)

Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
por: Steinman, Richard A., et al.
Publicado: (2012)

Differences in the renal antifibrotic signaling of serelaxin and zaprinast
por: Wetzl, Veronika, et al.
Publicado: (2015)

Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?
por: Chang, Yue, et al.
Publicado: (2020)

“Yap”-ing about the Antifibrotic Benefits of Prostacyclin
por: Huang, Steven K.
Publicado: (2019)

Antifibrotic drugs as therapeutic tools in resistant melanoma
por: Sanchez‐Laorden, Berta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s7ntphtrqirr2hq53tv0hcgd9f